Literature DB >> 25835204

Systemic Embolic Complications of Pulmonary Vein Angioplasty in Children.

Jesse J Esch1,2, Diego Porras3,4, Lisa Bergersen3,4, Kathy J Jenkins3,4, Audrey C Marshall3,4.   

Abstract

Pulmonary vein stenosis (PVS) carries significant morbidity and mortality for affected children, and its management often requires multiple angioplasty procedures. PVS angioplasty can be complicated by systemic embolic events such as stroke, but incidence and risk factors are poorly understood. We reviewed pediatric catheterizations involving PVS angioplasty and/or stent placement performed at Boston Children's Hospital between July 2005 and February 2014. A total of 406 cases were performed in 144 distinct patients. Patients underwent a median of two catheterizations, at median age 1 year and weight 6.9 kg. Eleven (2.7 %) catheterizations were complicated by clinically apparent systemic embolic events, comprising 10 strokes (one with associated hepatic embolism) and 1 renal infarct. Prevalence of clinically evident stroke among this cohort was 7.6 %. Using a prior (uncomplicated) catheterization to allow each patient to serve as their own control, we sought to identify potentially modifiable risk factors for systemic embolic events. Although this analysis was limited by low power, complicated and uncomplicated angioplasties did not appear to differ in case time, contrast dose, anticoagulation management, use of cutting balloons, number of catheter exchanges, or size of long sheath used. Significant non-embolic adverse events were common, occurring in 25 % of catheterizations. Systemic embolism appears to complicate PVS angioplasty at a rate much higher than that described for other congenital catheterizations. This risk may be inherent to the procedure rather than related to any modifiable or operator-dependent factors.

Entities:  

Keywords:  Angioplasty; Catheterization; Pulmonary vein stenosis; Stroke

Mesh:

Year:  2015        PMID: 25835204     DOI: 10.1007/s00246-015-1165-x

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  10 in total

1.  Mechanism of pulmonary vein stenosis in infants with normally connected veins.

Authors:  I M Sadr; P E Tan; M W Kieran; K J Jenkins
Journal:  Am J Cardiol       Date:  2000-09-01       Impact factor: 2.778

2.  A prospective phase II trial of vinblastine and methotrexate in multivessel intraluminal pulmonary vein stenosis in infants and children.

Authors:  Maliha Rehman; Kathy J Jenkins; Amy L Juraszek; Jean A Connor; Kimberlee Gauvreau; Muhammad Muneeb; Laureen M Sena; Steven D Colan; Terry Saia; Mark W Kieran
Journal:  Congenit Heart Dis       Date:  2011-11-11       Impact factor: 2.007

3.  Adverse event rates in congenital cardiac catheterization - a multi-center experience.

Authors:  Lisa Bergersen; Audrey Marshall; Kimberlee Gauvreau; Robert Beekman; Russel Hirsch; Susan Foerster; David Balzer; Julie Vincent; William Hellenbrand; Ralf Holzer; John Cheatham; John Moore; James Lock; Kathy Jenkins
Journal:  Catheter Cardiovasc Interv       Date:  2010-02-15       Impact factor: 2.692

4.  Surgical repair of pulmonary venous stenosis: a word of caution.

Authors:  Kirk R Kanter; Paul M Kirshbom; Brian E Kogon
Journal:  Ann Thorac Surg       Date:  2014-08-19       Impact factor: 4.330

5.  Surgical management of progressive pulmonary venous obstruction after repair of total anomalous pulmonary venous connection.

Authors:  F Lacour-Gayet; J Zoghbi; A E Serraf; E Belli; D Piot; C Rey; F Marçon; J Bruniaux; C Planché
Journal:  J Thorac Cardiovasc Surg       Date:  1999-04       Impact factor: 5.209

6.  Comparison of conventional and cutting balloon angioplasty for congenital and postoperative pulmonary vein stenosis in infants and young children.

Authors:  Lynn F Peng; James E Lock; Alan W Nugent; Kathy J Jenkins; Doff B McElhinney
Journal:  Catheter Cardiovasc Interv       Date:  2010-06-01       Impact factor: 2.692

7.  Cerebral infarction: incidence and risk factors after diagnostic and interventional cardiac catheterization--prospective evaluation at diffusion-weighted MR imaging.

Authors:  Karen A Büsing; Carla Schulte-Sasse; Stephan Flüchter; Tim Süselbeck; Karl K Haase; Wolfgang Neff; Jochen G Hirsch; Martin Borggrefe; Christoph Düber
Journal:  Radiology       Date:  2005-02-24       Impact factor: 11.105

8.  Total anomalous pulmonary venous connection: outcome of postoperative pulmonary venous obstruction.

Authors:  Anna N Seale; Hideki Uemura; Steven A Webber; John Partridge; Michael Roughton; Siew Y Ho; Karen P McCarthy; Sheila Jones; Lynda Shaughnessy; Jan Sunnegardh; Katarina Hanseus; Hakan Berggren; Sune Johansson; Michael L Rigby; Barry R Keeton; Piers E F Daubeney
Journal:  J Thorac Cardiovasc Surg       Date:  2012-08-11       Impact factor: 5.209

9.  Bilateral disease and early age at presentation are associated with shorter survival in patients with congenital heart disease and intraluminal pulmonary vein stenosis.

Authors:  Sowmya Balasubramanian; Maliha Rehman; Kimberlee Gauvreau; Kathy J Jenkins
Journal:  Congenit Heart Dis       Date:  2012-04-02       Impact factor: 2.007

10.  Pulmonary vein stenosis: the UK, Ireland and Sweden collaborative study.

Authors:  A N Seale; S A Webber; H Uemura; J Partridge; M Roughton; S Y Ho; K P McCarthy; S Jones; L Shaughnessy; J Sunnegardh; K Hanseus; M L Rigby; B R Keeton; P E F Daubeney
Journal:  Heart       Date:  2009-09-07       Impact factor: 5.994

  10 in total
  1 in total

1.  Selective pulmonary artery occlusion to treat hemoptysis associated with pulmonary venous obstruction.

Authors:  Melissa S W Yamauchi; Mary Hunt Martin; Harlan R Muntz; Ronald W Day
Journal:  Respir Med Case Rep       Date:  2017-10-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.